Chimeric Antigen Receptor (CAR) T-cell Therapy: The Current Success and the Future Promises in Combating Cancer
Marco L. Davila, MD, PhD
Thursday, April 30 8:00 AM – 9:30 AM
Moderator: Alessandro Villa, DDS, PhD, MPH
Description
This talk highlights the uses of CAR T-cell therapy to treat hematologic neoplasia and other solid tumors.
Learning Objectives
- Discuss the basic mechanism of action of CAR T-cell therapy and the current clinical evidence of the efficacy/superiority of CAR T-cell therapy.
- Elaborate on CAR T-cell therapy toxicity with emphases on the adverse effects on the head and neck region.
- Highlight the future direction of this innovative therapeutic approach.
|